(-)-demecolcine decreases expression ISO RGD:1312522 6480464 Demecolcine results in decreased expression of ATAD2 mRNA CTD PMID:23649840 1,1-dichloroethene increases expression ISO RGD:1312523 6480464 vinylidene chloride results in increased expression of ATAD2 mRNA CTD PMID:26682919 17beta-estradiol increases expression ISO RGD:1312522 6480464 Estradiol results in increased expression of ATAD2 mRNA CTD PMID:16474171 more ... 17beta-estradiol multiple interactions ISO RGD:1312522 6480464 [Estradiol co-treated with Progesterone] results in increased expression of ATAD2 mRNA, [Progesterone co-treated with Estradiol] results in increased expression of ATAD2 mRNA CTD PMID:17404688 , PMID:20660070 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1312522 6480464 Dihydrotestosterone results in increased expression of ATAD2 mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1312522 6480464 Tetrachlorodibenzodioxin results in decreased expression of ATAD2 mRNA CTD PMID:20106945 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ATAD2 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ATAD2 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1312523 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ATAD2 mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1312523 6480464 Tetrachlorodibenzodioxin affects the expression of ATAD2 mRNA CTD PMID:21570461 , PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1312522 6480464 Tetrachlorodibenzodioxin affects the expression of ATAD2 mRNA CTD PMID:22574217 2-methylcholine affects expression ISO RGD:1312522 6480464 beta-methylcholine affects the expression of ATAD2 mRNA CTD PMID:21179406 3-methylcholanthrene increases expression ISO RGD:1312523 6480464 Methylcholanthrene results in increased expression of ATAD2 mRNA CTD PMID:20713471 4-hydroxyphenyl retinamide increases expression ISO RGD:1312523 6480464 Fenretinide results in increased expression of ATAD2 mRNA CTD PMID:28973697 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of ATAD2 mRNA CTD PMID:24780913 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of ATAD2 mRNA CTD PMID:25825206 7,12-dimethyltetraphene increases expression ISO RGD:1312523 6480464 9 more ... CTD PMID:32553695 acetamide increases expression EXP 6480464 acetamide results in increased expression of ATAD2 mRNA CTD PMID:31881176 adefovir pivoxil increases expression ISO RGD:1312522 6480464 adefovir dipivoxil results in increased expression of ATAD2 mRNA CTD PMID:25596134 all-trans-retinoic acid decreases expression ISO RGD:1312522 6480464 Tretinoin results in decreased expression of ATAD2 mRNA CTD PMID:16249480 , PMID:33167477 arsane affects methylation ISO RGD:1312522 6480464 Arsenic affects the methylation of ATAD2 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1312522 6480464 Arsenic affects the methylation of ATAD2 gene CTD PMID:25304211 arsenite(3-) multiple interactions ISO RGD:1312522 6480464 arsenite inhibits the reaction [G3BP1 protein binds to ATAD2 mRNA] CTD PMID:32406909 arsenous acid multiple interactions ISO RGD:1312522 6480464 [Dasatinib co-treated with Arsenic Trioxide] results in decreased expression of ATAD2 mRNA CTD PMID:29266867 arsenous acid increases expression ISO RGD:1312522 6480464 Arsenic Trioxide results in increased expression of ATAD2 mRNA CTD PMID:29266867 azathioprine decreases expression ISO RGD:1312522 6480464 Azathioprine results in decreased expression of ATAD2 mRNA CTD PMID:22623647 benzo[a]pyrene increases expression ISO RGD:1312523 6480464 Benzo(a)pyrene results in increased expression of ATAD2 mRNA CTD PMID:20713471 benzo[a]pyrene multiple interactions ISO RGD:1312523 6480464 [Benzo(a)pyrene results in increased activity of AHR protein] which results in decreased expression of ATAD2 mRNA CTD PMID:32553695 benzo[a]pyrene decreases expression ISO RGD:1312522 6480464 Benzo(a)pyrene results in decreased expression of ATAD2 mRNA CTD PMID:20064835 more ... benzo[a]pyrene decreases expression ISO RGD:1312523 6480464 Benzo(a)pyrene results in decreased expression of ATAD2 mRNA CTD PMID:19770486 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1312522 6480464 7 more ... CTD PMID:19150397 , PMID:20382639 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1312522 6480464 7 more ... CTD PMID:26238291 bisphenol A increases expression ISO RGD:1312522 6480464 bisphenol A results in increased expression of ATAD2 mRNA CTD PMID:16474171 bisphenol A multiple interactions ISO RGD:1312522 6480464 [[ginger extract results in increased abundance of Oils more ... CTD PMID:31601247 , PMID:33376534 bisphenol A affects expression ISO RGD:1312522 6480464 bisphenol A affects the expression of ATAD2 mRNA CTD PMID:30903817 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ATAD2 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1312523 6480464 bisphenol A results in decreased expression of ATAD2 mRNA CTD PMID:26063408 bisphenol A decreases expression ISO RGD:1312522 6480464 bisphenol A results in decreased expression of ATAD2 mRNA CTD PMID:29275510 cadmium dichloride affects expression ISO RGD:1312522 6480464 Cadmium Chloride affects the expression of ATAD2 mRNA CTD PMID:25596134 caffeine affects phosphorylation ISO RGD:1312522 6480464 Caffeine affects the phosphorylation of ATAD2 protein CTD PMID:35688186 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of ATAD2 mRNA CTD PMID:18500788 CGP 52608 multiple interactions ISO RGD:1312522 6480464 CGP 52608 promotes the reaction [RORA protein binds to ATAD2 gene] CTD PMID:28238834 chloroacetaldehyde affects expression ISO RGD:1312522 6480464 chloroacetaldehyde affects the expression of ATAD2 mRNA CTD PMID:25596134 chromium(6+) affects expression ISO RGD:1312523 6480464 chromium hexavalent ion affects the expression of ATAD2 mRNA CTD PMID:28472532 cidofovir anhydrous increases expression ISO RGD:1312522 6480464 Cidofovir results in increased expression of ATAD2 mRNA CTD PMID:25596134 cisplatin decreases phosphorylation ISO RGD:1312523 6480464 Cisplatin results in decreased phosphorylation of ATAD2 protein CTD PMID:22006019 cisplatin multiple interactions ISO RGD:1312522 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of ATAD2 mRNA CTD PMID:27392435 cisplatin decreases expression ISO RGD:1312522 6480464 Cisplatin results in decreased expression of ATAD2 mRNA CTD PMID:27392435 cisplatin increases expression ISO RGD:1312522 6480464 Cisplatin results in increased expression of ATAD2 mRNA CTD PMID:25596134 , PMID:27594783 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of ATAD2 mRNA CTD PMID:22023808 clodronic acid increases expression ISO RGD:1312522 6480464 Clodronic Acid results in increased expression of ATAD2 mRNA CTD PMID:25596134 cobalt dichloride decreases expression ISO RGD:1312522 6480464 cobaltous chloride results in decreased expression of ATAD2 mRNA CTD PMID:19376846 copper atom multiple interactions ISO RGD:1312522 6480464 [NSC 689534 binds to Copper] which results in decreased expression of ATAD2 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1312522 6480464 [NSC 689534 binds to Copper] which results in decreased expression of ATAD2 mRNA CTD PMID:20971185 copper(II) sulfate decreases expression ISO RGD:1312522 6480464 Copper Sulfate results in decreased expression of ATAD2 mRNA CTD PMID:19549813 coumarin decreases phosphorylation ISO RGD:1312522 6480464 coumarin results in decreased phosphorylation of ATAD2 protein CTD PMID:35688186 coumestrol multiple interactions ISO RGD:1312522 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 coumestrol increases expression ISO RGD:1312522 6480464 Coumestrol results in increased expression of ATAD2 mRNA CTD PMID:19167446 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of ATAD2 mRNA CTD PMID:27523638 cyclosporin A decreases expression ISO RGD:1312522 6480464 Cyclosporine results in decreased expression of ATAD2 mRNA CTD PMID:20106945 more ... dexamethasone multiple interactions ISO RGD:1312522 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of ATAD2 mRNA CTD PMID:26424790 diarsenic trioxide increases expression ISO RGD:1312522 6480464 Arsenic Trioxide results in increased expression of ATAD2 mRNA CTD PMID:29266867 diarsenic trioxide multiple interactions ISO RGD:1312522 6480464 [Dasatinib co-treated with Arsenic Trioxide] results in decreased expression of ATAD2 mRNA CTD PMID:29266867 dibutyl phthalate decreases expression ISO RGD:1312523 6480464 Dibutyl Phthalate results in decreased expression of ATAD2 mRNA CTD PMID:17361019 , PMID:21266533 dicrotophos decreases expression ISO RGD:1312522 6480464 dicrotophos results in decreased expression of ATAD2 mRNA CTD PMID:28302478 dioxygen decreases expression ISO RGD:1312522 6480464 Oxygen deficiency results in decreased expression of ATAD2 mRNA CTD PMID:25596134 dorsomorphin multiple interactions ISO RGD:1312522 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATAD2 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1312522 6480464 Doxorubicin results in decreased expression of ATAD2 mRNA CTD PMID:29803840 Enterolactone multiple interactions ISO RGD:1312522 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATAD2 mRNA CTD PMID:19167446 Enterolactone increases expression ISO RGD:1312522 6480464 2, 3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of ATAD2 mRNA CTD PMID:19167446 ethanol decreases expression ISO RGD:1312523 6480464 Ethanol results in decreased expression of ATAD2 mRNA CTD PMID:29018328 fulvestrant multiple interactions ISO RGD:1312522 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of ATAD2 gene CTD PMID:31601247 genistein increases expression ISO RGD:1312522 6480464 Genistein results in increased expression of ATAD2 mRNA CTD PMID:16474171 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of ATAD2 mRNA CTD PMID:22061828 glycerol 2-phosphate multiple interactions ISO RGD:1312522 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of ATAD2 mRNA CTD PMID:26424790 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of ATAD2 mRNA CTD PMID:21396975 isoprenaline increases expression ISO RGD:1312523 6480464 Isoproterenol results in increased expression of ATAD2 mRNA CTD PMID:20003209 ivermectin decreases expression ISO RGD:1312522 6480464 Ivermectin results in decreased expression of ATAD2 protein CTD PMID:32959892 L-ascorbic acid multiple interactions ISO RGD:1312522 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of ATAD2 mRNA CTD PMID:26424790 lidocaine increases expression EXP 6480464 Lidocaine results in increased expression of ATAD2 mRNA CTD PMID:35283115 lucanthone decreases expression ISO RGD:1312522 6480464 Lucanthone results in decreased expression of ATAD2 mRNA CTD PMID:21148553 methyl methanesulfonate increases expression ISO RGD:1312522 6480464 Methyl Methanesulfonate results in increased expression of ATAD2 mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:1312522 6480464 methylmercuric chloride results in increased expression of ATAD2 mRNA CTD PMID:28001369 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of ATAD2 gene CTD PMID:33148267 N-methyl-4-phenylpyridinium decreases expression ISO RGD:1312522 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of ATAD2 mRNA CTD PMID:24810058 nickel atom increases expression ISO RGD:1312522 6480464 Nickel results in increased expression of ATAD2 mRNA CTD PMID:25583101 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of ATAD2 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of ATAD2 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1312523 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ATAD2 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ATAD2 mRNA CTD PMID:34911549 paracetamol increases expression ISO RGD:1312522 6480464 Acetaminophen results in increased expression of ATAD2 mRNA CTD PMID:22230336 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of ATAD2 mRNA CTD PMID:33387578 perfluorononanoic acid decreases expression ISO RGD:1312522 6480464 perfluoro-n-nonanoic acid results in decreased expression of ATAD2 mRNA CTD PMID:32588087 perfluorooctanoic acid decreases expression ISO RGD:1312522 6480464 perfluorooctanoic acid results in decreased expression of ATAD2 protein CTD PMID:26879310 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of ATAD2 gene CTD PMID:33148267 phenobarbital increases expression ISO RGD:1312523 6480464 Phenobarbital results in increased expression of ATAD2 mRNA CTD PMID:19482888 phenobarbital affects expression ISO RGD:1312523 6480464 Phenobarbital affects the expression of ATAD2 mRNA CTD PMID:23091169 phenobarbital multiple interactions ISO RGD:1312523 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ATAD2 mRNA] CTD PMID:19482888 phytoestrogen increases expression ISO RGD:1312522 6480464 Phytoestrogens results in increased expression of ATAD2 mRNA CTD PMID:18310284 pirinixic acid multiple interactions ISO RGD:1312522 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ATAD2 mRNA CTD PMID:19710929 piroxicam decreases expression ISO RGD:1312522 6480464 Piroxicam results in decreased expression of ATAD2 mRNA CTD PMID:21858171 progesterone multiple interactions ISO RGD:1312522 6480464 [Estradiol co-treated with Progesterone] results in increased expression of ATAD2 mRNA, [Progesterone co-treated with Estradiol] results in increased expression of ATAD2 mRNA CTD PMID:17404688 , PMID:20660070 progesterone increases expression ISO RGD:1312522 6480464 Progesterone results in increased expression of ATAD2 mRNA CTD PMID:17404688 resveratrol increases expression ISO RGD:1312522 6480464 resveratrol results in increased expression of ATAD2 mRNA CTD PMID:19167446 resveratrol multiple interactions ISO RGD:1312522 6480464 [Coumestrol co-treated with Resveratrol] results in increased expression of ATAD2 mRNA, [Plant Extracts co-treated with Resveratrol] results in increased expression of ATAD2 mRNA CTD PMID:19167446 , PMID:23557933 SB 431542 multiple interactions ISO RGD:1312522 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATAD2 mRNA CTD PMID:27188386 senecionine increases expression EXP 6480464 senecionine results in increased expression of ATAD2 mRNA CTD PMID:32419051 Senkirkine increases expression EXP 6480464 senkirkine results in increased expression of ATAD2 mRNA CTD PMID:32419051 silicon dioxide decreases expression ISO RGD:1312522 6480464 Silicon Dioxide analog results in decreased expression of ATAD2 mRNA CTD PMID:23806026 sodium arsenite decreases expression ISO RGD:1312522 6480464 sodium arsenite results in decreased expression of ATAD2 mRNA CTD PMID:29301061 sodium arsenite increases expression ISO RGD:1312522 6480464 sodium arsenite results in increased expression of ATAD2 mRNA CTD PMID:34032870 succimer multiple interactions ISO RGD:1312523 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ATAD2 mRNA CTD PMID:21641980 sunitinib decreases expression ISO RGD:1312522 6480464 Sunitinib results in decreased expression of ATAD2 mRNA CTD PMID:31533062 tert-butyl hydroperoxide decreases expression ISO RGD:1312522 6480464 tert-Butylhydroperoxide results in decreased expression of ATAD2 mRNA CTD PMID:15336504 tetrachloromethane increases expression ISO RGD:1312523 6480464 Carbon Tetrachloride results in increased expression of ATAD2 mRNA CTD PMID:27339419 , PMID:31919559 thapsigargin increases expression ISO RGD:1312523 6480464 Thapsigargin results in increased expression of ATAD2 protein CTD PMID:24648495 thapsigargin decreases expression ISO RGD:1312522 6480464 Thapsigargin results in decreased expression of ATAD2 mRNA CTD PMID:22378314 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ATAD2 mRNA CTD PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of ATAD2 mRNA CTD PMID:25729387 trichloroethene decreases methylation EXP 6480464 Trichloroethylene results in decreased methylation of ATAD2 gene CTD PMID:27618143 trichostatin A decreases expression ISO RGD:1312522 6480464 trichostatin A results in decreased expression of ATAD2 mRNA CTD PMID:26272509 trichostatin A multiple interactions ISO RGD:1312522 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATAD2 mRNA CTD PMID:27188386 triclosan decreases expression ISO RGD:1312522 6480464 Triclosan results in decreased expression of ATAD2 mRNA CTD PMID:30510588 trimellitic anhydride increases expression ISO RGD:1312523 6480464 trimellitic anhydride results in increased expression of ATAD2 mRNA CTD PMID:19042947 tungsten decreases expression ISO RGD:1312523 6480464 Tungsten results in decreased expression of ATAD2 mRNA CTD PMID:30912803 urethane decreases expression ISO RGD:1312522 6480464 Urethane results in decreased expression of ATAD2 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1312523 6480464 Valproic Acid affects the expression of ATAD2 mRNA CTD PMID:17292431 valproic acid decreases expression ISO RGD:1312522 6480464 Valproic Acid results in decreased expression of ATAD2 mRNA CTD PMID:27188386 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of ATAD2 mRNA CTD PMID:23034163 vincristine decreases expression ISO RGD:1312522 6480464 Vincristine results in decreased expression of ATAD2 mRNA CTD PMID:23649840